Pharmaceutical giant AstraZeneca has today agreed to mass-produce a COVID-19 vaccine developed by Oxford University scientists.

Human trials of the experimental jab – called ChAdOx1 nCoV-19 – started last week and the first results are expected in mid-June.
If proven to protect against the deadly virus, the deal will allow the UK to access the vaccine ‘as early as possible’, the university said today.
Details of the agreement – described by Health Secretary Matt Hancock as ‘hugely welcome news’ – are set to be finalized in the coming weeks.

Developing vaccinations can take up to a decade and scientists have said finding an effective jab within 18 months would be ‘unprecedented’.